Depression in Parkinson's disease
Identifieur interne : 001207 ( Main/Curation ); précédent : 001206; suivant : 001208Depression in Parkinson's disease
Auteurs : D. J. Burn [Royaume-Uni]Source :
- European Journal of Neurology [ 1351-5101 ] ; 2002-11.
English descriptors
Abstract
Depression in Parkinson's disease (PD) is a common complication, with a major impact on quality of life. Failure to recognize and treat depression can lead to premature and inappropriate discontinuation of antiparkinsonian therapies. Cited frequency for depression in PD varies between 2.7 and 70%. Methodological differences account for much of the disparity. The aetiology of depression in PD is complex, with ‘tonic’ (slowly changing and persistent) and ‘phasic’ (short‐lived and fluctuating) components. Both depression and anxiety may predate the onset of the motor disorder by some years. Hedonistic homeostatic dysregulation is a cyclical mood disorder associated with excessive intake of dopaminergic therapies, inappropriate for the motor state. Negative affective symptoms occur on attempted reduction of medication, reinforcing the abnormal medication pattern. The Montgomery‐Åsberg Depression Rating Scale and the Hamilton Rating Scale for Depression have good diagnostic sensitivity and specificity for assessing depression in PD. There is a dearth of sizeable, placebo‐controlled studies for evaluating drug treatment of depression in PD. Dopaminergic drugs have variable antidepressant properties. Selective serotonin reuptake inhibitors are currently the most commonly prescribed group of antidepressants in the depressed PD patient. Depression in the PD patient may be associated with a more rapid deterioration in cognitive and motor functions.
Url:
DOI: 10.1046/j.1468-1331.9.s3.6.x
Links toward previous steps (curation, corpus...)
- to stream Main, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001422
Links to Exploration step
ISTEX:569434693B95C1ACDEE3A2DF7DB5FE0AE9C0F689Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Depression in Parkinson's disease</title><author><name sortKey="Burn, D J" sort="Burn, D J" uniqKey="Burn D" first="D. J." last="Burn">D. J. Burn</name><affiliation wicri:level="1"><mods:affiliation>Regional Neurosciences Centre, Newcastle General Hospital, Newcastle upon Tyne, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Regional Neurosciences Centre, Newcastle General Hospital, Newcastle upon Tyne</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:569434693B95C1ACDEE3A2DF7DB5FE0AE9C0F689</idno><date when="2002" year="2002">2002</date><idno type="doi">10.1046/j.1468-1331.9.s3.6.x</idno><idno type="url">https://api.istex.fr/document/569434693B95C1ACDEE3A2DF7DB5FE0AE9C0F689/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">001422</idno><idno type="wicri:Area/Main/Curation">001207</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Depression in Parkinson's disease</title><author><name sortKey="Burn, D J" sort="Burn, D J" uniqKey="Burn D" first="D. J." last="Burn">D. J. Burn</name><affiliation wicri:level="1"><mods:affiliation>Regional Neurosciences Centre, Newcastle General Hospital, Newcastle upon Tyne, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Regional Neurosciences Centre, Newcastle General Hospital, Newcastle upon Tyne</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j">European Journal of Neurology</title><idno type="ISSN">1351-5101</idno><idno type="eISSN">1468-1331</idno><imprint><publisher>Blackwell Science, Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2002-11">2002-11</date><biblScope unit="volume">9</biblScope><biblScope unit="supplement">s3</biblScope><biblScope unit="page" from="44">44</biblScope><biblScope unit="page" to="54">54</biblScope></imprint><idno type="ISSN">1351-5101</idno></series><idno type="istex">569434693B95C1ACDEE3A2DF7DB5FE0AE9C0F689</idno><idno type="DOI">10.1046/j.1468-1331.9.s3.6.x</idno><idno type="ArticleID">ENE0080</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1351-5101</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's disease</term><term>aetiology</term><term>clinical features</term><term>depression</term><term>epidemiology</term><term>treatment</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Depression in Parkinson's disease (PD) is a common complication, with a major impact on quality of life. Failure to recognize and treat depression can lead to premature and inappropriate discontinuation of antiparkinsonian therapies. Cited frequency for depression in PD varies between 2.7 and 70%. Methodological differences account for much of the disparity. The aetiology of depression in PD is complex, with ‘tonic’ (slowly changing and persistent) and ‘phasic’ (short‐lived and fluctuating) components. Both depression and anxiety may predate the onset of the motor disorder by some years. Hedonistic homeostatic dysregulation is a cyclical mood disorder associated with excessive intake of dopaminergic therapies, inappropriate for the motor state. Negative affective symptoms occur on attempted reduction of medication, reinforcing the abnormal medication pattern. The Montgomery‐Åsberg Depression Rating Scale and the Hamilton Rating Scale for Depression have good diagnostic sensitivity and specificity for assessing depression in PD. There is a dearth of sizeable, placebo‐controlled studies for evaluating drug treatment of depression in PD. Dopaminergic drugs have variable antidepressant properties. Selective serotonin reuptake inhibitors are currently the most commonly prescribed group of antidepressants in the depressed PD patient. Depression in the PD patient may be associated with a more rapid deterioration in cognitive and motor functions.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001207 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 001207 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Curation
|type= RBID
|clé= ISTEX:569434693B95C1ACDEE3A2DF7DB5FE0AE9C0F689
|texte= Depression in Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |